Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Systems Pathology Company (SPC) was a Seattle-based digital pathology and artificial intelligence company that specialized in automating tissue evaluation for preclinical drug development. Founded in 2006 by Gary L. Knutsen, the company developed the Computer Assisted Pathology System (CAPS™), a proprietary software platform designed to enhance traditional toxicologic pathology through advanced analytical imaging and AI. The technology aimed to improve the efficiency and accuracy of pathologists by automating routine aspects of tissue analysis, thereby accelerating the preclinical reporting process. In 2009, the company was acquired by Charles River Laboratories for approximately $24 million to be integrated into their global preclinical service offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Systems Pathology Company.